Researchers found that inhibiting GSK-3 led to less defects in the axonal transport process and less neuronal cell death, while inhibiting ERK1 led to more transport problems and more cell death.

One protein mitigates Huntington’s disease while another one exacerbates it by regulating the huntingtin protein’s movement ...